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WHAT THIS PAPER ADDS
 Our experimental study demonstrated that extravascular administration of sclerotic agents shows no detrimental inﬂuences on
vessels ﬁrst. The results implicated the importance of catheterisation during sclerotherapy for vascular malformations.a r t i c l e i n f o
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Objectives: Sclerotherapy is useful for the treatment of arteriovenous vascular malformations. However,
intravascular administration of sclerotic agents into small arteriovenous niduses is often difﬁcult.
Extravascular administration of sclerotic agents causes reduction of vascular ﬂow on Doppler echo during
clinical sclerotherapy. Therefore, we aimed to investigate whether the extravascular injection of sclerotic
agents affects tiny vessels.
Design: Animal study.
Materials: The effect of extravascular injection of sclerotic agents on vessels was investigated using rat
femoral and superﬁcial inferior epigastric vessels.
Methods: After surgical exposure of vessels, absolute ethanol, 5% ethanolamine oleate and 3% polidocanol
were injected into perivascular surrounding tissues, and their effect on vessels was evaluated after 14
days using histology and coloured silicone rubber injection.
Results: The integrity of the vascular lumen, endothelial cells and vascular patency were not affected by
injection of sclerotic agents.
Conclusions: Attenuation of vascular ﬂow of an arteriovenous shunt after extravascular injection of
sclerotic agents is transient and/or trivial and does not cause disruption of vessels. Therefore, sclerotic
agents should be delivered to obtain sufﬁcient destruction of arteriovenous malformation lesions and
blood ﬂow.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Among various types of congenital vascular malformations,
arteriovenous malformations (AVMs) are featured by a wide range
of clinical presentations and unpredictable courses, making their
treatment difﬁcult. Surgical eradication of arteriovenous niduses of
an AVM offers the possibility of complete cure. However, it is often
difﬁcult or impossible because of excessive bleeding, resulting in
severe morbidities in appearance as well as function, especially in
the head and neck.1e3 Therefore, embolisation and/or percutaneous: þ81 422 46 0138.
ta).
ciety for Vascular Surgery. Publishesclerotherapy are often employed as independent therapies or as
adjunct therapies with surgical resection.
During these approaches, a decrease in vascular ﬂow of lesions
caused by proximal blockage of arteries supplying AVMs can result
in the recurrence of lesions being nourished by much more
complicated collateral feeding arteries.1,4,5 Moreover, re-feeding of
lesions after proximal blockage even enhances the expansion of
original lesions in a short period of time.1,4,5 Therefore, during
percutaneous sclerotherapy for AVMs, it is necessary to inject
sclerotic agents into tiny arteriovenous shunting vessels.1,6
However, catheterisation into tiny shunting vessels is often tech-
nically difﬁcult. In our experiences of Doppler-ultrasonography-d by Elsevier Ltd. All rights reserved.
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extravascular instillation of sclerotic agents caused attenuation of
vascular ﬂow of arteriovenous shunts, although it was unclear if the
attenuation was actually caused by damage to vessels and whether
it resulted in reduction of AVMs.
Herein, we are interested in whether extravascularly injected
sclerotic agents affect tiny vessels. As far as we know, detrimental
inﬂuences of intravascularly administrated sclerotic agents on
vessels,7e10 extravascular surrounding tissues such as nerve,
muscle8 and skin11 and effects of extravascularly administrated
sclerotic agents on muscle and nerve12 have been previously
reported. However, no reports have described the effect of extrav-
ascularly administered sclerotic agents on vessels.
To investigate the detrimental inﬂuences of extravascularly
injected sclerotic agents on tiny vessels, we employed arteries and
veins of rat groin fossa as an experimentalmodel. Following injection
of sclerotic agents, their effects on vessels, especially on patency,
were evaluatedwithhistologyand coloured silicone rubber injection.
Materials and Methods
Experimental model
Wistar rats weighing 300e350 g were used. All the operative
procedures were performed under general anaesthesia with
intraperitoneal administration of 50 mg kg1 pentobarbital
sodium. The study was designed in accordance with the Laboratory
Animal Guidelines of Kyorin University School of Medicine.
Right femoral vessels and superﬁcial inferior epigastric (SIE)
vessels of the rat were employed to investigate the effects of
extravascularly administered sclerotic agents on vessels. The
subject vessels were easily identiﬁed through an inguinal incision
without detachment of transparent surrounding tissues (Fig. 1).
After identiﬁcation of the anterior surface of vessels, 1 ml of scle-
rotic agents was injected with a 30-G ﬁne needle into the
surrounding tissues close to the vessels.
Sclerotic agents
Absolute ethanol (ET), 5% ethanolamine oleate (EO) (composed
of a 1:1 mixture of 10% EO (Oldamin, Fuji Chemical Industry Co.,
Toyama, Japan) and pure water) and 3% polidocanol (PL) (Polido-
casclerol, Zeria Pharmaceutical Co., Ltd., Tokyo, Japan) were used as
sclerotic agents because these are known as strong sclerotic
agents used for the percutaneous sclerotherapy of vascular
malformations.6,8,11,12Figure 1. Schematic description of the femoral vessels and superﬁcial inferior
epigastric vessels in the rat. The anterior part of the femoral vessels and superﬁcial
inferior epigastric vessels are minimally dissected to identify the vessels through an
inguinal incision. Vessels are easily viewed through transparent surrounding tissues
without detachment of surrounding tissues. Yellow arrowheads indicate the femoral
vessels and red arrowheads indicate the superﬁcial inferior epigastric vessels.Experimental design
A total of 36 rats were allotted to six groups (n ¼ 6 for each
group). Three groups of rats were used to investigate the effect of
ET, EO and PL on femoral vessels and the other three groups were
used to investigate the effect of ET, EO and PL on SIE vessels. No
speciﬁc control was used for the current study because of famil-
iarity with the animals and assays used.8,13,14 No speciﬁc blinding
was assigned because we considered that observational bias would
not affect the results owing to clarity of the end point. During the
experiment, seven animals died, possibly because of overdosage of
anaesthesia, and these animals were replaced.
The effect of sclerotic agents on vessels
Two weeks after injection, vessels were inspected through
inguinal incision. After careful inspection of the patency of vessels,
segments of the vessels and extravascular surrounding tissues were
obtained for pathological inspection in four rats for each experi-
mental group. In two rats in each group, 1 ml of yellow-coloured
silicone rubber (Microﬁl; Flow Tech, Inc., Carver, Mass.) was injec-
ted through the proximal end of the femoral vessels for the
conﬁrmation of vascular patency.
Results
Changes immediately after the injection of sclerotic agents
With injection of ET, the colour of transparent surrounding
tissues turned immediately to non-translucent white, while EO and
PL did not cause any discolouration with injection. Dilated veins
appeared attenuated in patches with the pressure of pooled scle-
rotic agents. However, none of the segments showed complete
obstruction in femoral and SIE vessels (Fig. 2).
Changes 14 days after the injection of sclerotic agents
Fourteen days after the injection of sclerotic agents, we looked
for changes in the tissue through the same incision. In all rats, we
found that the subcutaneous tissues surrounding the vessels were
ﬁbrous; however, no obvious changes were observed in the femoral
and SIE vessels themselves (Fig. 2). On pathological investigation,
en-bloc necrotic nidus, which is usually found in avascular necrosis,
was not observed in any of the samples. EO- and PL-injected
samples showed enhanced inﬂammatory cell inﬁltration in loose
areolar tissue, which enfolded vessels, and part of this cellular
inﬁltration appeared to invade the outer membrane of vessels.
These inﬁltrating changes were not obvious in the ET-injected
samples. The integrity of the vascular lumen, endothelial cells
and patency was maintained in all the samples (Fig. 3). Vascular
patency was directly conﬁrmed by injecting yellow-coloured sili-
cone rubber through the proximal end of femoral vessels (Fig. 4).
Discussion
Intravascularly administered sclerosants are known to cause
endothelial destruction and exposure of subendothelial collagen,
resulting in activation of blood coagulation.15 The mechanics for
endothelial destruction are considered to be speciﬁc to each scle-
rosant, such as cellular ﬁxation for ET, and cellular membrane
disruption for surface activating agents such as EO and PL.7
In our previous experimental study, we evaluated the destruc-
tive ability of intravascularly administered sclerotic agents on
surrounding tissues such as nerves8 and skin11 for the assessment
of sclerotherapy-associated complications. Strong sclerotic agents
Figure 4. Representative ﬁndings of femoral and SIE vessels after silicon rubber
injection. Using yellow-coloured silicon rubber, it was conﬁrmed that there was no
obstruction of vessels observed with injection of absolute ethanol (ET), 5% ethanol-
amine oleate (EO) and 3% polidocanol (PL).
Figure 2. Representative ﬁndings of before, immediately after, and 14 days after the
injection of sclerotic agents into surrounding tissue of femoral vessels (a) and superﬁcial
inferior epigastric vessels (b). No obstruction of vessels was observed with injection of
absolute ethanol (ET), 5% ethanolamine oleate (EO) and 3% polidocanol (PL).
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tissues by leaking out of damaged vascular walls. Therefore, it is
possible that extravascularly administered sclerotic agents are also
able to destroy vessels. However, in our present study, we did not
ﬁnd any damage to vascular endothelial cells, as shown by injection
of sclerotic agents into adjacent surrounding tissues, still less the
obstruction of vessels even in tiny vessels in the rat groin fossa.
Two reasons could explain the different effects between intra-
vascularly administered agents on surrounding tissues and
extravascularly administered agents on endothelial cells. One
reason could be structural differences in the administrated area. In
our previous study,8,11 because we used rat veins with partial orFigure 3. Representative ﬁndings of histology of femoral and SIE vessels. Fourteen
days after injection of absolute ethanol (ET), 5% ethanolamine oleate (EO) and 3%
polidocanol (PL), segments of vessels were obtained with surrounding tissues and
stained with haematoxylineeosin. The integrity of the vascular lumen is conserved. No
obstruction of vessels is recognised. Red arrowheads indicate arteries and blue
arrowheads indicate veins. The yellow scale bar indicates 500 mm.transient ﬂow obstruction as an experimental model, the volume of
the vascular lumen was relatively limited and, therefore, intravas-
cular spaces attained comparatively high pressure with injection of
agents, resulting in overﬂow of sclerotic agents outward. On the
other hand, extravascular spaces in the rat groin fossa are
composed of thin pliable tissues, and sclerotic agents are easily
separated by thick and strong vascular walls. Second, the existence
of vascular ﬂow is the reason for differences. Since destructive
effects of sclerotic agents on cells are correlated with the duration
of contact,7 continuously retained vascular current may improve
washing out of sclerotic agents if extravascularly administrated
agents reach the internal surface of the vascular wall (i.e., endo-
thelial cells).
In our experimental setting, extravascularly administrated
sclerotic agents had little effect on vessels in the rat groin fossa. We
consider that differences in structure and circulation dynamics of
human AVMs and tiny vessels in the rat, such as a thicker vascular
wall and higher vascular ﬂow in human AVMs, enhance the resis-
tivity to extravascularly administered sclerotic agents. Further-
more, increased capillary ﬂow in AVM lesions may enhance
clearance of interstitially deposited sclerotic agents. Therefore, no
destructive inﬂuences are expected with extravascular adminis-
tration of sclerotic agents.
On the other hand, extravascular interstitial tissues do not show
en-bloc necrotic nidus formation with direct administration of
sclerotic agents in situ. We consider that changes after sclerotic
agents are different from typical tissue necrosis, such as those
observed in avascular necrosis, because vascular structure is mostly
preserved, although cellular necrosis and degeneration of the
extracellular matrix occur to some degree. Further study is required
to investigate this possibility in detail.
Based on our ﬁndings, we conclude that attenuation of vascular
ﬂow of arteriovenous shunts after extravascular injection of scle-
rotic injection observed on Doppler ultrasonography is transient
and/or trivial, and does not cause disruption of vessels. In the
treatment of AVMs, maximal effort should be made to deliver
sclerotic agents into the vascular lumen to attain sufﬁcient
destruction of lesions and regulate blood ﬂow.
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